Pharma losses due to inneffective clinical development strategies
According to industry reports, the cost of drug development can exceed $800.0 million and take more than 10 years for a drug to go from inception to market. These numbers are daunting as companies and shareholders look to produce life-saving medicines and recoup their enormous investment.
Considering this dilemma, the Strategic Research Institute has organized the Clinical Drug Development Summit. The two day meeting, scheduled for October 23-24 in East Brunswick, New Jersey, USA, will bring together senior pharmaceutical leaders from around the globe to discuss opportunities and challenges for reducing overall drug development cost while speeding products to market.
The Summit will focus on solutions and strategies chosen by biopharma executives with such people in mind and will feature three concurrent conferences and five industry focused tracks. Conferences include: Strategic Clinical Outsourcing; Clinical Data Management; and Phase IV Clinical Trials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze